生殖補助医療 (ART) の世界市場

当レポートでは、世界の生殖補助医療 (ART) の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー
• 市場力学と成長要因
• 新興技術
• セグメント分析
• 地域分析
• 結論

第2章 市場概要

• 市場定義
• ARTの種類
• 技術的背景
• 卵巣刺激コントロール
• ゴナドトロピン放出ホルモン（GnRH）拮抗薬および作動薬のサイクル
• 卵子採取
• 受精
• 着床前遺伝子検査（PGT）
• 体外成熟
• 胚移植
• 機器
• PESTEL分析
• 米国関税法が生殖補助医療市場に与える影響
• サプライチェーンへの影響
• 国内生産の機会
• 結論

第3章 市場力学

• 市場力学
• 市場促進要因
• 不妊率の上昇
• ARTにおける技術の進歩
• 不妊治療に関する認識と受容の向上
• 市場抑制要因
• 高額な治療費
• 倫理的および法的問題
• 市場機会
• 不妊治療クリニックの増加
• 新興国における成長機会

第4章 新興技術と開発

• 重要ポイント
• 人工子宮施設
• AIを活用した体外受精
• 配偶子（卵子・精子）選別におけるAIの活用
• 胚選別におけるAIの活用
• 治療スケジュールの最適化におけるAIの活用

第5章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場内訳：処置別
• 重要ポイント
• 体外受精
• 体外受精市場：施術サブタイプ別
• 人工授精
• その他
• 市場内訳：製品別
• 重要ポイント
• 機器
• 試薬・培地
• アクセサリー・使い捨て品
• 市場内訳：エンドユーザー別
• 重要ポイント
• 不妊治療クリニック
• 病院
• その他
• 地理的内訳
• 市場内訳：地域別
• 重要ポイント
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 重要ポイント
• 生殖補助医療市場の主要企業
• 戦略分析
• コラボレーション・パートナーシップ
• 買収・投資
• 製品承認

第7章 付録

• 調査手法
• 出典
• 頭字語
• 企業プロファイル
• COOK
• COOPERSURGICAL INC.
• ESCO MEDICAL
• FERTIPRO NV
• GENEA BIOMEDX
• HAMILTON THORNE
• INVITROCARE INC.
• KITAZATO CORP.
• NIDACON INTERNATIONAL AB
• VITROLIFE AB

List of Tables

• Summary Table : Global Market for Assisted Reproductive Technologies, by Procedure, Through 2030
• Table 1 : Price Range of Various ART Procedures, 2024
• Table 2 : Global Market for Assisted Reproductive Technologies, by Procedure, Through 2030
• Table 3 : Global Market for In Vitro Fertilization ART Procedures, by Region, Through 2030
• Table 4 : Global Market for In Vitro Fertilization ART Procedures, by Procedure Sub-Type, Through 2030
• Table 5 : Global Market for In Vitro Fertilization for Frozen Non-Donor, by Region, Through 2030
• Table 6 : Global Market for In Vitro Fertilization for Fresh Non-donor, by Region, Through 2030
• Table 7 : Global Market for In Vitro Fertilization for Frozen Donor, by Region, Through 2030
• Table 8 : Global Market for In Vitro Fertilization for Fresh Donor, by Region, Through 2030
• Table 9 : Global Market for Artificial Insemination ART Procedure, by Region, Through 2030
• Table 10 : Global Market for Other ART Procedures, by Region, Through 2030
• Table 11 : Global Market for Assisted Reproductive Technologies, by Product, Through 2030
• Table 12 : Global Market for Instruments in Assisted Reproductive Technologies, by Region, Through 2030
• Table 13 : Global Market for Reagents and Media in Assisted Reproductive Technologies, by Region, Through 2030
• Table 14 : Global Market for Accessories and Disposables in Assisted Reproductive Technologies, by Region, Through 2030
• Table 15 : Global Market for Assisted Reproductive Technologies, by End User, Through 2030
• Table 16 : Global Market for Assisted Reproductive Technologies for Fertility Clinics, by Region, Through 2030
• Table 17 : Global Market for Assisted Reproductive Technologies for Hospitals, by Region, Through 2030
• Table 18 : Global Market for Assisted Reproductive Technologies for Other End Users, by Region, Through 2030
• Table 19 : Global Market for Assisted Reproductive Technologies, by Region, Through 2030
• Table 20 : North American Market for Assisted Reproductive Technologies, by Procedure, Through 2030
• Table 21 : North American Market for In Vitro Fertilization, by Procedure Type, Through 2030
• Table 22 : North American Market for Assisted Reproductive Technologies, by Product, Through 2030
• Table 23 : North American Market for Assisted Reproductive Technologies, by End User, Through 2030
• Table 24 : European Market for Assisted Reproductive Technologies, by Procedure, Through 2030
• Table 25 : European Market for In Vitro Fertilization, by Procedure Type, Through 2030
• Table 26 : European Market for Assisted Reproductive Technologies, by Product, Through 2030
• Table 27 : European Market for Assisted Reproductive Technologies, by End User, Through 2030
• Table 28 : Asia-Pacific Market for Assisted Reproductive Technologies, by Procedure, Through 2030
• Table 29 : Asia-Pacific Market for In Vitro Fertilization, by Procedure Type, Through 2030
• Table 30 : Asia-Pacific Market for Assisted Reproductive Technologies, by Product, Through 2030
• Table 31 : Asia-Pacific Market for Assisted Reproductive Technologies, by End User, Through 2030
• Table 32 : RoW Market for Assisted Reproductive Technologies, by Procedure, Through 2030
• Table 33 : RoW Market for In Vitro Fertilization, by Procedure Type, Through 2030
• Table 34 : RoW Market for Assisted Reproductive Technologies, by Product, Through 2030
• Table 35 : RoW Market for Assisted Reproductive Technologies, by End User, Through 2030
• Table 36 : Collaborations and Partnerships: Assisted Reproductive Technologies Market, 2023-2025
• Table 37 : Acquisitions and Investments: Assisted Reproductive Technologies Market, 2024 and 2025
• Table 38 : Product Approvals: Assisted Reproductive Technologies Market, 2023 and 2024
• Table 39 : Information Sources for this Report
• Table 40 : Abbreviations Used in this Report
• Table 41 : Cook: Company Snapshot
• Table 42 : Cook: Product Portfolio
• Table 43 : CooperSurgical Inc.: Company Snapshot
• Table 44 : CooperSurgical Inc.: Product Portfolio
• Table 45 : CooperSurgical Inc.: News/Key Developments, 2024
• Table 46 : Esco Medical: Company Snapshot
• Table 47 : Esco Medical: Product Portfolio
• Table 48 : Esco Medical: News/Key Developments, 2025
• Table 49 : Fertipro NV: Company Snapshot
• Table 50 : Fertipro NV: Product Portfolio
• Table 51 : Fertipro NV: News/Key Developments, 2023
• Table 52 : Genea BIOMEDX: Company Snapshot
• Table 53 : Genea BIOMEDX: Product Portfolio
• Table 54 : Genea BIOMEDX: News/Key Developments, 2023 and 2024
• Table 55 : Hamilton Thorne: Company Snapshot
• Table 56 : Hamilton Thorne: Product Portfolio
• Table 57 : Hamilton Thorne: News/Key Developments, 2024 and 2025
• Table 58 : InVitroCare Inc.: Company Snapshot
• Table 59 : InVitroCare Inc.: Product Portfolio
• Table 60 : Kitazato Corp.: Company Snapshot
• Table 61 : Kitazato Corp.: Product Portfolio
• Table 62 : Kitazato Corp.: News/Key Developments, 2024
• Table 63 : NidaCon International AB: Company Snapshot
• Table 64 : NidaCon International AB: Product Portfolio
• Table 65 : Vitrolife AB: Company Snapshot
• Table 66 : Vitrolife AB: Financial Performance, FY 2023 and 2024
• Table 67 : Vitrolife AB: Product Portfolio
• Table 68 : Vitrolife AB: News/Key Developments, 2025

List of Figures

• Summary Figure : Global Market Shares of Assisted Reproductive Technologies, by Procedure, 2024
• Figure 1 : PESTEL Analysis: Assisted Reproductive Technologies Market
• Figure 2 : Market Dynamics of Assisted Reproductive Technologies
• Figure 3 : Global Market Shares of Assisted Reproductive Technologies, by Procedure, 2024
• Figure 4 : Global Market Shares of In Vitro Fertilization ART Procedures, by Region, 2024
• Figure 5 : Global Market Shares of In Vitro Fertilization ART Procedures, by Procedure Sub-Type, 2024
• Figure 6 : Global Market Shares of In Vitro Fertilization for Frozen Non-Donor, by Region, 2024
• Figure 7 : Global Market Shares of In Vitro Fertilization for Fresh Non-donor, by Region, 2024
• Figure 8 : Global Market Shares of In Vitro Fertilization for Frozen Donor, by Region, 2024
• Figure 9 : Global Market Shares of In Vitro Fertilization for Fresh Donor, by Region, 2024
• Figure 10 : Global Market Shares of Artificial Insemination ART Procedures, by Region, 2024
• Figure 11 : Global Market Shares of Other ART Procedures, by Region, 2024
• Figure 12 : Global Market Shares of Assisted Reproductive Technologies, by Product, 2024
• Figure 13 : Global Market Shares of Instruments in Assisted Reproductive Technologies, by Region, 2024
• Figure 14 : Global Market Shares of Reagents and Media in Assisted Reproductive Technologies, by Region, 2024
• Figure 15 : Global Market Shares of Accessories and Disposables in Assisted Reproductive Technologies, by Region, 2024
• Figure 16 : Global Market Shares of Assisted Reproductive Technologies, by End User, 2024
• Figure 17 : Global Market Shares of Assisted Reproductive Technologies for Fertility Clinics, by Region, 2024
• Figure 18 : Global Market Shares of Assisted Reproductive Technologies for Hospitals, by Region, 2024
• Figure 19 : Global Market Shares of Assisted Reproductive Technologies for Other End Users, by Region, 2024
• Figure 20 : Global Market Shares of Assisted Reproductive Technologies, by Region, 2024
• Figure 21 : North American Market Shares of Assisted Reproductive Technologies, by Procedure, 2024
• Figure 22 : European Market Shares of Assisted Reproductive Technology, by Procedure, 2024
• Figure 23 : Asia-Pacific Market Shares of Assisted Reproductive Technologies, by Procedure, 2024
• Figure 24 : RoW Market Shares of Assisted Reproductive Technology, by Procedure, 2024
• Figure 25 : Vitrolife AB: Revenue Share, by Business Unit, FY 2024
• Figure 26 : Vitrolife AB: Revenue Share, by Region/Country, FY 2024

The report provides an analysis of the global assisted reproductive technologies market and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented into procedure, product, end user, and region. The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape.

Report Scope

This short report provides an overview of the global assisted reproductive technologies market and analyzes market trends. The report includes global revenue ($ millions) for base year data (2024), estimated data for 2025, and forecasts of compound annual growth rates (CAGRs) from 2025 through 2030. Based on procedures, the market is segmented into in vitro fertilization (IVF), artificial insemination and others. The IVF procedure segment is further sub-segmented based on procedure type into frozen non-donor, fresh non-donor, frozen donor and fresh donor. Based on product, the assisted reproductive technologies market is divided into instruments, reagents and media, accessories and disposables. The market is segmented into fertility clinics, hospitals, and others based on end users. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape. It concludes with an analysis of the competitive landscape of prominent companies in the global assisted reproductive technologies market. It also has a dedicated section of company profiles that covers details such as overview, product portfolio and strategic developments of major companies in the market.

Report Includes

• Overview and analysis of the global markets for assisted reproductive technologies (ART)
• Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects of the global ART market, and a corresponding market share analysis based on product type, technology (procedure) type, end user and region
• Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impacts of macroeconomic variables
• Discussion of the underlying opportunities and potential, with the integration of emerging networks of fertility clinic services, reproductive drugs and ongoing research activities in reproductive medicine
• Insights derived from Porter's Five Forces model, global supply chain analyses and case studies
• An analysis of patents, emerging trends and the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Profiles of the leading companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Market Definition
• Types of ART
• Technology Background
• Controlled Ovarian Stimulation
• Gonadotropin-Releasing Hormone (GnRH) Antagonist and Agonist Cycles
• Oocyte Retrieval
• Fertilization
• Preimplantation Genetic Testing (PGT)
• In Vitro Maturation
• Embryo Transfer
• Equipment
• PESTEL Analysis
• Impact of U.S. Tariff Laws on the Assisted Reproductive Technologies Market
• Effects on Supply Chains
• Opportunities for Local Production
• Conclusion

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Infertility Rates
• Technological Advances in ART
• Increasing Awareness and Acceptance Regarding Fertility Treatments
• Market Restraints
• High Costs of Treatment
• Ethical and Legal Issues
• Market Opportunities
• Growing Number of Fertility Clinics
• Growth Opportunities in Emerging Economies

Chapter 4 Emerging Technologies and Developments

• Key Takeaways
• Artificial Womb Facility
• Artificial Intelligence-Based IVF
• AI in Gamete Selection
• AI in Embryo Selection
• AI in Treatment Routine

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Procedure
• Key Takeaways
• In Vitro Fertilization
• IVF Market, by Procedure Sub-Type
• Artificial Insemination
• Other Procedures
• Market Breakdown by Product
• Key Takeaways
• Instruments
• Reagents and Media
• Accessories and Disposables
• Market Breakdown by End User
• Key Takeaways
• Fertility Clinics
• Hospitals
• Other End Users
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Key Takeaways
• Key Companies in the Assisted Reproductive Technologies Market
• Strategic Analysis
• Collaborations and Partnerships
• Acquisitions and Investments
• Product Approvals

Chapter 7 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• COOK
• COOPERSURGICAL INC.
• ESCO MEDICAL
• FERTIPRO NV
• GENEA BIOMEDX
• HAMILTON THORNE
• INVITROCARE INC.
• KITAZATO CORP.
• NIDACON INTERNATIONAL AB
• VITROLIFE AB